Researchers engineer enucleated cells to deliver therapeutics precisely to diseased tissues
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health report successfully removing the nucleus out of a type of ubiquitous cell, known as enucleation,...
Lisbon inaugurates biotechnology lab – TheMayor.EU
Lisbon inaugurates biotechnology lab
It is open to all citizens and is a space for testing out new ideas in the field
On 13 January, Lisbon acquired a new space for innovation – the Bio Lab...
Low-temperature DeNOx catalyst for reducing ultrafine particle emission
Recently, there has been growing demand for DeNOx catalysts that can treat nitrogen oxides (NOx) at low temperatures, to increase energy efficiency when processing flue gas in industrial combustion facilities. NOx are emitted during...
UTA working with DFW aerospace companies to enable autonomous flight systems
A University of Texas at Arlington aerospace engineer is teaming with industry partners to develop control systems for autonomous aerial vehicles that will increase their safety and detect structural issues.
Credit: UT Arlington
A University of...
National Award Honors research leading to habitat restoration for people, birds
In Missouri, USDA Forest Service science was instrumental in habitat restoration, culminating in the reintroduction of a songbird that had disappeared from the state a century ago. In Baltimore, research is helping parishioners and...
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens...
The founder of Moderna’s incubator, Flagship Pioneering, penned his first annual letter charting the four driving forces behind the biotech industry’s future with an emphasis on digital biology and platform technologies. Noubar Afeyan, Ph.D., who...
Breast Cancer Drugs Can Be Repurposed for Cancers with Splice Mutation
Cancers with mutations in the SF3B1 gene respond to PARP inhibitors—a type of drug used to treat cancers with mutations in the BRCA1 and BRCA2 genes, scientists at the Queen’s University of Belfast and...
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials...
Mithra has brushed off a missed co-primary endpoint in one of its two phase 3 clinical trials and given a bullish update (PDF) on the menopause drug, which it expects to gain a global partner...
Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021
Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth.
Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over...
EMA sets out plan to accelerate clinical trials, reduce administrative burden
The European Medicines Agency (EMA) wants to speed up your clinical trials. Through the Accelerating Clinical Trials in the EU (ACT EU) initiative, the EMA and other bodies have set out (PDF) 10 actions they...
